Best oncologists in Spain: TOP 44 doctors

This doctor has experience in endocrine treatment, collaborating on studies aimed at overcoming resistance to hormone therapy. They have also been involved in numerous phase 1, 2 and 3 studies in breast and melanoma, which have led to the approval of new drugs in new indications. Their main area of interest lies in immunotherapy for melanoma treatment and patient care. They have participated in trials that have led to the approval of cdk4/6 palbociclib and ribociclib inhibitors in the first line of metastatic breast cancer, and Pembrolizumab in the first line of metastatic melanoma, as well as the combination of Nivolumab and Ipilimumab. They are a member of the Breast Cancer Unit and Melanoma Unit at the Vall d'Hebron University Hospital and the Vall d'Hebron Institute of Oncology. This doctor is an experienced oncologist with expertise in breast cancer and melanoma treatments, including endocrine therapy, immunotherapy, and patient care. They have been involved in numerous clinical trials leading to the approval of new drugs in new indications.

Professor Felip is a medical doctor from the UAB who specializes in thoracic malignancy management and is responsible for thoracic cancer trials. She is a current member of various societies related to oncology and has authored many peer-reviewed articles and book chapters in the field. She is also an associate professor at the UAB and professor of medicine at the Universitat de Vic, and is involved in the training of medical students and residents.

Dr. Jaume Mora Graupera is a pediatric oncologist specializing in the treatment of neuroblastomas, gliomas, Ewing's sarcomas, and Wilms' tumors. He is the Director of the Hematology Oncology Department and Developmental Tumors Laboratory at Sant Joan De Déu - Barcelona Children’s Hospital. He received his medical degree from the University of Barcelona, went on to complete specialty training in pediatrics and fellowships in pediatric hematology oncology and molecular pathology of pediatric cancer at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center in the USA. He has won multiple awards and is a member of various medical organizations.

Experienced surgeon with expertise in the fields of Peritoneal Oncology, Melanoma and Sarcoma Surgery, Laparoscopic and Robotic Surgery, and Hepato-Biliary and Pancreatic Surgery. Speaker at National and International Congresses on Surgical Treatment of Advanced Abdominal and Pelvic Cancers, author and co-author of scientific publications of national and international importance, and investigator of clinical trials of oncological surgery of national and international importance. Member of national and international scientific communities.

• Specializes in Oncology, utilizing microsurgery and non-invasive radiosurgery techniques.
• Trained in Oncology in Sweden, Switzerland, Canada, and the USA.
• Performs over 200 Oncology-related operations annually.
• Member of European Society of Brain Tumors Neurosurgery, with a focus on Oncologic cases.
• Part of the American Academy of Minimally Invasive Spinal Medicine, with relevance to spinal tumors.
• Offers online consultations for Oncology patients, ensuring accessibility and convenience.

• Renowned Oncologist Dr. Jaume Capdevila, specializes in digestive and pancreatic cancers.
• Trained internationally, including a fellowship in Endocrine Oncology in Sweden.
• Dr. Capdevila holds a Medical Oncology specialization from Santa Creu i Sant Pau Hospital.
• Active member of EORTC, ESMO, ENETS, ASCO, GEMCAD, TTD, and GETHI.
• Certified in Medicine and Surgery, focuses on evidence-based cancer treatments.
• Provides online consultations for patients seeking oncology expertise.

Onco-Urologist

Prof. Fermin Mearin Manrique is an experienced Spanish gastroenterologist with over 40 years of practice. He specializes in diagnostics and treatment of digestive system conditions, with a focus on functional digestive disorders management. He has extensive academic and professional experience, having written over 400 scientific works and being a member of numerous organizations.

Dr. Carlos Ballesta López is a top specialist in pancreatic cancer treatment, general and digestive surgery with 30+ years of experience. He is a pioneer in laparoscopic surgery, which reduces pain and recovery time for patients. He has performed over 12,000 operations of abdominal and digestive surgery by laparoscopy, and has organized courses of laparoscopic surgery for Spanish and foreign surgeons. He has a Bachelor of Medicine and Surgery from the University of Granada (1973), Medical specialist in General Surgery (1977) and Gastroenterology (1979), and is currently the Director of the Dr. Ballesta Laparoscopic Center.

Radiation oncologist

General and digestive tract surgeon with expertise in minimally invasive laparoscopic surgery. Has held Associate Clinical Lecturer and Lecturer positions at the University of Navarre School of Medicine. Member of the Spanish Association of Surgeons, Spanish Society of Obesity Surgery, and European Association for Endoscopic Surgery.

Dr. Lana Bijelic is an oncological surgeon and specialist in peritoneal carcinomatosis who joined the Teknon Oncology Institute’s Carcinomatosis Surgical Group in 2019. She is certified by the American Board of Surgery and is a member of various scientific communities, including the American College of Surgeons and the Society of Surgical Oncology. She has held various research and clinical positions, and has been awarded numerous academic achievements.

Oncologist, Specialist in skin cancer treatment

Academic Education:

• Bachelor of Medicine and Surgery. University of Barcelona.
• Doctor in medicine. University of Barcelona. Extraordinary prize for doctoral thesis.
• Training in translational research thanks to a post-doctoral stay at Memorial Sloan-Kettering Cancer Center (New York, USA).

Professional Experience:

• Medical Oncologist specialized in urological cancer. Her areas of expertise are prostate cancer, kidney, bladder and urinary tract cancer, and testicular cancer.
• She currently works as a Senior Consultant in the Medical Oncology Service of the Hospital Clínic de Barcelona, ​​where she is responsible for urological cancer. 
• At HM Delfos, from Medical Oncology, she is responsible for the care of patients with urological cancer, from a multidisciplinary approach in coordination with the different specialists (urology, radiotherapy, pathology) through joint work and the Tumor Committee. She is also responsible for the introduction of new therapies and the development of clinical trial projects in this area.

Scientific and Teaching Activity:

• Associate Professor of the Faculty of Medicine of the Clinical Hospital. University of Barcelona. 
• Teaching in the subject of Medical Oncology, of the 5th year of the Degree in Medicine and Surgery at the University of Barcelona. She has been the director of several Final Degree projects for medical students in ​​urological cancer.
• Teacher and Director of the subject "Prostate Cancer" of the Master of Biomedicine. University of Barcelona.
• Teacher and Director of the subject "Comprehensive management of the uro-oncological patient", of the Master of Uro-Oncology of Advanced Medical Competences. University of Barcelona. 
• Direction of several doctoral theses on prostate cancer.
• Extensive experience in the training of Residents in Medical Oncology at the Clinical Hospital de Barcelona.
• Extensive teaching experience in scientific courses and symposiums.
• Internship tutor for students of the Master in Art Therapy at Escuela Metáfora. Art therapy in cancer patients at Hospital Clinic.
• Coordinator of Mindfulness training workshops in Oncology.
• Clinical research:   Extensive experience as principal investigator of multiple clinical trials, phase I, II and III, of new therapies in urological cancer.
• Translational research: Researcher at the August Pi i Sunyer Biomedical Research Institute (IDIBAPS). Leader of the Prostate Cancer working group, within the Translational Genomics Laboratory and Targeted Therapy in Solid Tumors. Her fundamental line of research is based on the investigation of resistance mechanisms to prostate cancer treatments and the study of biomarkers that allow progress towards personalized medicine in this disease.
• She has published more than 140 scientific articles in international journals.

Areas of Professional Interest:

• Her interest as a professional is to provide the best care for patients with urological cancer from all areas: the best care on an individual basis and offer them the best available treatment or the possibility of having access to new treatments within clinical trials. 
• In addition, she has a great interest in promoting comprehensive care for patients and their families.

Dr. Antonio Alcaraz is a Spanish uro-oncologist and transplantologist with over 30 years of experience and 500 successful operations, specializing in the treatment of prostate cancer, kidney, bladder, and other urogenital system pathologies using minimally invasive and robotic systems, as well as congenital pathologies in children. He is a member of several prestigious urological societies.